Development of Non-Toxic Carbon Dots as Bone-Specific Carrier for Drug Delivery
开发无毒碳点作为药物输送的骨特异性载体
基本信息
- 批准号:1809060
- 负责人:
- 金额:$ 41.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
NON-TECHNICAL ABSTRACTThis project advances our understanding of Carbon dots (C-dots) physical and chemical properties for their application in biological systems. Size, morphology, surface chemistry and method of preparation govern how C-dots interact with biological tissues. C-dots derived from carbon powder are unique in that they bind to mineralized bones with high affinity and specificity. By characterizing the physical and chemical properties that confer these C-dots their unique bone-binding properties, this project will advance our understanding of the interactions between C-dots and mineralized tissues. This is an essential step towards developing C-dots as tools for bone imaging and diagnostic tools, and for the treatment and repair of bone fractures and degenerative diseases (e.g., osteoporosis) that would impact US health. Additionally, this work will support the training of graduate and undergraduate students, fostering inquiry-based research and scientific collaboration essential to develop the skills needed in a thriving US scientific workforce. TECHNICAL ABSTRACTThe goal of this work is to understand the physical and chemical properties of Carbon nanoparticles (C-dots) for their development as bone-specific drug carriers. C-dots are a new emerging class of nanomaterials whose biological applications in imaging, diagnostics and therapeutics critically depend on their size, molecular structure and material of origin. One particular class of C-dots synthesized from carbon powder have the unique property of binding to mineralized bones in vivo. To advance our understanding of the interactions between C-dots and mineralized tissues this project will (1) determine the intrinsic chemical and physical properties of C-dots that are related to their high affinity and specificity towards mineralized bones, (2) determine how different surface functionalities influence the interactions between C-dots and mineralized bones, and (3) functionally test the ability of C-dots to deliver drugs to bones. By characterizing C-dots' unique bone binding properties, this work will not only uncover the physicochemical principles that allow C-dots binding to bones, but will also discern the molecular principles need to target new nanomaterials to mineralized tissue at the exclusion of other tissues. Thus, the findings of this work will have broad intellectual implications for nanomaterial chemistry and engineering, as well as advancing the development of bone imaging and diagnostic tools for the repair and treatment of bone fractures and degenerative diseases.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
非技术摘要本项目推进了我们对碳量子点(C-点)物理和化学性质的理解,以便在生物系统中应用。 尺寸、形态、表面化学和制备方法决定了C点如何与生物组织相互作用。 来源于碳粉的C点是独特的,因为它们以高亲和力和特异性结合到矿化骨上。 通过表征赋予这些C点独特的骨结合特性的物理和化学特性,该项目将促进我们对C点与矿化组织之间相互作用的理解。 这是开发C点作为骨成像和诊断工具以及治疗和修复骨折和退行性疾病(例如,骨质疏松症),这将影响美国的健康。 此外,这项工作将支持研究生和本科生的培训,促进基于探究的研究和科学合作,这对培养蓬勃发展的美国科学劳动力所需的技能至关重要。技术摘要本工作的目标是了解碳纳米颗粒(C点)的物理和化学性质,以开发其作为骨特异性药物载体。 C点是一类新兴的纳米材料,其在成像、诊断和治疗方面的生物学应用严重依赖于其尺寸、分子结构和来源材料。 由碳粉合成的一类特殊的C点具有与体内矿化骨结合的独特性质。 为了促进我们对C点和矿化组织之间相互作用的理解,该项目将(1)确定与C点对矿化骨的高亲和力和特异性相关的C点的内在化学和物理性质,(2)确定不同的表面功能如何影响C点和矿化骨之间的相互作用,以及(3)功能性地测试C点将药物递送至骨的能力。通过表征C-dots独特的骨结合特性,这项工作不仅将揭示允许C-dots与骨结合的物理化学原理,而且还将识别出将新纳米材料靶向矿化组织而排除其他组织所需的分子原理。因此,这项工作的发现将对纳米材料化学和工程产生广泛的知识影响,并推动骨成像和诊断工具的发展,用于骨折和退行性疾病的修复和治疗。该奖项反映了NSF的法定使命,并被认为值得通过使用基金会的知识价值和更广泛的影响审查标准进行评估来支持。
项目成果
期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tyrosinase enzyme Langmuir monolayer: Surface chemistry and spectroscopic study
- DOI:10.1016/j.jcis.2019.12.118
- 发表时间:2020-03-22
- 期刊:
- 影响因子:9.9
- 作者:Paudyal, Suraj;Sharma, Shiv K.;Leblanc, Roger M.
- 通讯作者:Leblanc, Roger M.
pH and redox triggered doxorubicin release from covalently linked carbon dots conjugates
- DOI:10.1039/d0nr08381j
- 发表时间:2021-03-14
- 期刊:
- 影响因子:6.7
- 作者:Hettiarachchi, Sajini D.;Cilingir, Emel Kirbas;Leblanc, Roger M.
- 通讯作者:Leblanc, Roger M.
Versatile drug nanocarrier assembly via conjugation of distinct carbon dots
- DOI:10.48317/imist.prsm/morjchem-v8i4.22304
- 发表时间:2020-08
- 期刊:
- 影响因子:1.1
- 作者:Yiqun Zhou;Jiuyan Chen;Nikolay Miloserdov;Wei Zhang;Keenan J. Mintz;B. Ferreira;M. Mićić;
- 通讯作者:Yiqun Zhou;Jiuyan Chen;Nikolay Miloserdov;Wei Zhang;Keenan J. Mintz;B. Ferreira;M. Mićić;
Tryptophan carbon dots and their ability to cross the blood-brain barrier
- DOI:10.1016/j.colsurfb.2019.01.031
- 发表时间:2019-04-01
- 期刊:
- 影响因子:5.8
- 作者:Mintz, Keenan J.;Mercado, Guillaume;Leblanc, Roger M.
- 通讯作者:Leblanc, Roger M.
3D printed ABS/paraffin hybrid rocket fuels with carbon dots for superior combustion performance
- DOI:10.1016/j.combustflame.2020.11.024
- 发表时间:2021-03
- 期刊:
- 影响因子:4.4
- 作者:Cagri Oztan;É. Ginzburg;Mert Akin;Yiqun Zhou;R. Leblanc;V. Coverstone
- 通讯作者:Cagri Oztan;É. Ginzburg;Mert Akin;Yiqun Zhou;R. Leblanc;V. Coverstone
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger Leblanc其他文献
O10 - Fungal microbial translocation changes during treated acute and chronic HIV infection
- DOI:
10.1016/s2055-6640(20)30369-1 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Vikram Mehraj;Rayoun Ramendra;Cecilia Costiniuk;Bertrand Lebouché;Rosalie Ponte;Réjean Thomas;Jason Szabo;Pierre Coté;Roger Leblanc;Jean-Guy Baril;Cécile Tremblay;Nicole Bernard;Donald C. Sheppard;Jean-Pierre Routy - 通讯作者:
Jean-Pierre Routy
Cotinine : A dual action drug with multiple benefits against Alzheimer's disease
可替宁:一种双重作用药物,对阿尔茨海默病具有多种功效
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
Valentina Echeverria;Sarah Burgess;Ross Zeitlin;Arghya Barman;Garima Thakur;Hideyo Inouye;Edmundo Feris;Steven Buckingham;Daniel Kirschner;Takashi Mori;Roger Leblanc;Rajeev Prabhakar;David Sattelle;Gary W. Arendash - 通讯作者:
Gary W. Arendash
Rose Bengal Photodynamic Antimicrobial Therapy: A Review of the Intermediate-Term Clinical and Surgical Outcomes
- DOI:
10.1016/j.ajo.2022.08.004 - 发表时间:
2022-11-01 - 期刊:
- 影响因子:4.200
- 作者:
Paula A. Sepulveda-Beltran;Harry Levine;Diego S. Altamirano;Jaime D. Martinez;Heather Durkee;Keenan Mintz;Roger Leblanc;Jana D'Amato Tóthová;Darlene Miller;Jean-Marie Parel;Guillermo Amescua - 通讯作者:
Guillermo Amescua
DP2 - Soluble ST2 rings the alarm for gut damage and immune activation in primary HIV infection
- DOI:
10.1016/s2055-6640(20)31104-3 - 发表时间:
2016-05-01 - 期刊:
- 影响因子:
- 作者:
Vikram Mehraj;Mohammad-Ali Jenabian;Rosalie Ponte;Bertrand Lebouché;Cecilia Costiniuk;Réjean Thomas;Jean-Guy Baril;Roger Leblanc;Joseph Cox;Cécile Tremblay;Jean-Pierre Routy - 通讯作者:
Jean-Pierre Routy
P38 - Identifying smoking cessation targets for people living with HIV and HIV-HCV
- DOI:
10.1016/s2055-6640(20)30418-0 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Blake Linthewaite;Joseph Cox;Marina Klein;Jacques Fallu;Hansi Peiris;Syim Salahuddin;Jean-Pierre Routy;Bertrand Lebouche;Marie-Josée Brouillette;Jason Szabo;Andreas Giannakis;Roger Leblanc;Mohammad-Ali Jenabian;Sean Gilman;Cecilia Costiniuk - 通讯作者:
Cecilia Costiniuk
Roger Leblanc的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger Leblanc', 18)}}的其他基金
EAGER: Carbon Dot-Based Transformative COVID-19 Therapy
EAGER:基于碳点的变革性 COVID-19 疗法
- 批准号:
2041413 - 财政年份:2020
- 资助金额:
$ 41.04万 - 项目类别:
Standard Grant
EAGER: Assay Optimization for Highly Sensitive Detection of Human Cardiac Troponin I
EAGER:人心肌肌钙蛋白 I 高灵敏度检测的测定优化
- 批准号:
1355317 - 财政年份:2013
- 资助金额:
$ 41.04万 - 项目类别:
Continuing Grant
EAGER: New Approach for Biosensing in Cardiac Diagnosis
EAGER:心脏诊断生物传感的新方法
- 批准号:
0944290 - 财政年份:2009
- 资助金额:
$ 41.04万 - 项目类别:
Standard Grant
Combinatorial Surface Chemistry: Novel Approach Towards Biomimetic in 2D
组合表面化学:二维仿生的新方法
- 批准号:
0416095 - 财政年份:2004
- 资助金额:
$ 41.04万 - 项目类别:
Continuing Grant
Combinatorial Surface Chemistry: Novel Approach Towards Biomimetic Sensor Development
组合表面化学:仿生传感器开发的新方法
- 批准号:
0091390 - 财政年份:2001
- 资助金额:
$ 41.04万 - 项目类别:
Standard Grant
Purchase of MALDI-TOF Mass Spectrometer
购买MALDI-TOF质谱仪
- 批准号:
0077930 - 财政年份:2000
- 资助金额:
$ 41.04万 - 项目类别:
Standard Grant
U.S.-Japan Cooperative Science: Studies of Molecular Recognition Formed in Systematic Molecular Assemblies
美日合作科学:系统分子组装中形成的分子识别研究
- 批准号:
9981375 - 财政年份:2000
- 资助金额:
$ 41.04万 - 项目类别:
Standard Grant
Upgrade of Scanning Probe Microscopy System
扫描探针显微镜系统升级
- 批准号:
9709217 - 财政年份:1997
- 资助金额:
$ 41.04万 - 项目类别:
Standard Grant
Purchase of a 300 MHz NMR Spectrometer
购买 300 MHz 核磁共振波谱仪
- 批准号:
9613929 - 财政年份:1997
- 资助金额:
$ 41.04万 - 项目类别:
Standard Grant
相似国自然基金
Non-CG DNA甲基化平衡大豆产量和SMV抗性的分子机制
- 批准号:32301796
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
long non-coding RNA(lncRNA)-activatedby TGF-β(lncRNA-ATB)通过成纤维细胞影响糖尿病创面愈合的机制研究
- 批准号:LQ23H150003
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
染色体不稳定性调控肺癌non-shedding状态及其生物学意义探索研究
- 批准号:82303936
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
变分法在双临界Hénon方程和障碍系统中的应用
- 批准号:12301258
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
BTK抑制剂下调IL-17分泌增强CD20mb对Non-GCB型弥漫大B细胞淋巴瘤敏感性
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
Non-TAL效应子NUDX4通过Nudix水解酶活性调控水稻白叶枯病菌致病性的分子机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
一种新non-Gal抗原CYP3A29的鉴定及其在猪-猕猴异种肾移植体液排斥反应中的作用
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
非经典BAF(non-canonical BAF,ncBAF)复合物在小鼠胚胎干细胞中功能及其分子机理的研究
- 批准号:32170797
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
Non-Oberbeck-Boussinesq效应下两相自然对流问题的建模及高效算法研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
植物胚乳发育过程中non-CG甲基化调控的分子机制探究
- 批准号:LQ21C060001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Development of a growth method CTS films for the realization of next-generation solar cells which are low-cost, non-toxic, and highly-efficient
开发CTS薄膜生长方法,实现低成本、无毒、高效的下一代太阳能电池
- 批准号:
23K13697 - 财政年份:2023
- 资助金额:
$ 41.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer
开发有效且无毒的类毒素来预防非黑色素瘤皮肤癌
- 批准号:
10562891 - 财政年份:2023
- 资助金额:
$ 41.04万 - 项目类别:
STTR Phase I: Development of an Additively-Manufactured, Non-Toxic, Advanced Storable Hybrid Rocket Propulsion System
STTR 第一阶段:开发增材制造、无毒、先进的可储存混合火箭推进系统
- 批准号:
2127098 - 财政年份:2022
- 资助金额:
$ 41.04万 - 项目类别:
Standard Grant
Enhancing Maritime Industry Resilience and Sustainability by Development of Non-toxic Anti-Fouling Marine Coatings
通过开发无毒防污船舶涂料增强海事工业的弹性和可持续性
- 批准号:
570691-2021 - 财政年份:2022
- 资助金额:
$ 41.04万 - 项目类别:
Alliance Grants
Enhancing Maritime Industry Resilience and Sustainability by Development of Non-toxic Anti-Fouling Marine Coatings
通过开发无毒防污船舶涂料增强海事工业的弹性和可持续性
- 批准号:
570691-2021 - 财政年份:2021
- 资助金额:
$ 41.04万 - 项目类别:
Alliance Grants
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections
开发针对侵袭性真菌感染的无毒两性霉素 B 衍生物
- 批准号:
10405641 - 财政年份:2018
- 资助金额:
$ 41.04万 - 项目类别:
Development of non-toxic amphotericin B derivatives targeting invasive fungal infections
开发针对侵袭性真菌感染的无毒两性霉素 B 衍生物
- 批准号:
10183149 - 财政年份:2018
- 资助金额:
$ 41.04万 - 项目类别:
Development of non-toxic carbon dots as bone-specific carrier for drug delivery
开发无毒碳点作为药物输送的骨特异性载体
- 批准号:
1809419 - 财政年份:2018
- 资助金额:
$ 41.04万 - 项目类别:
Continuing Grant
Technology development for the non-invasive assessment of exposure to toxic metals
有毒金属暴露无创评估技术开发
- 批准号:
203611-2012 - 财政年份:2016
- 资助金额:
$ 41.04万 - 项目类别:
Discovery Grants Program - Individual
Development of non-toxic and color-tunable rare-earth nanoparticles and application of biomarkers
无毒、颜色可调的稀土纳米粒子的研制及生物标志物的应用
- 批准号:
16K05750 - 财政年份:2016
- 资助金额:
$ 41.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)